复苏性主动脉腔内球囊阻断术:你需要知道什么
出血仍是平民与军事人群创伤死亡的主要原因之一。复苏性主动脉腔内球囊阻断术(REBOA)是一种微创技术,可作为复苏性开胸术等最大侵入性方法的替代,用作临时措施防止失血并过渡到确定性止血。过去十年REBOA使用增加,越来越多文献提示与未接受REBOA的患者相比,其可能改善特定出血性创伤患者的结局;REBOA也用于特定非创伤病例。审慎的患者选择、掌握置入技术细节及明确适应证是最大化其疗效的关键。
要点
- REBOA是微创临时措施,用于防止失血并为确定性止血争取时间,可替代复苏性开胸术等最大侵入性方法。
- REBOA由受过训练的人员即可置入,不需要外科专长。
- 过去十年使用增加,文献提示与未接受REBOA者相比可能改善特定出血性创伤患者的结局。
- REBOA也用于特定非创伤病例。
- 审慎患者选择、掌握置入技术、明确适应证是最大化疗效的关键。
适用人群与场景
- 平民与军事人群中创伤性损伤出血的患者。
- 特定非创伤病例。
处置流程与药物剂量
- REBOA作为临时措施,用于防止失血并过渡到确定性止血。
- 由受过训练的人员置入,不需要外科专长。
研究设计与关键结果
- 综述指出过去十年REBOA使用增加,越来越多文献提示与未接受REBOA的患者相比,其可能改善特定出血性创伤患者的结局。
证据类型、等级与局限
- 证据类型:综述(What You Need To Know review)。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,审慎的患者选择、掌握REBOA置入技术细节及明确适应证,是最大化其作为出血性休克缓解工具疗效的关键。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Hemorrhage remains one of the leading causes of death from traumatic injury in both the civilian and military populations. Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a minimally invasive technique that can be used to treat hemorrhage in the critically ill. An alternative to maximally invasive methods such as resuscitative thoracotomy, REBOA is a temporizing measure to prevent exsanguination and allow for transition to definitive hemorrhage control. It is easily deployed by trained users and does not require surgical expertise to place. Its use has increased over the past decade with a growing body of literature that suggests it improves outcomes in select hemorrhagic trauma patients compared with patients who do not receive REBOA. REBOA has also been used for select nontraumatic cases. Judicious patient selection, knowing the technical aspects of placing REBOA, and clarity regarding its indications are key to maximize its efficacy as a mitigatory tool in hemorrhagic shock. This "What You Need To Know" review presents current evidence regarding use of REBOA for the acute care surgeon.
参考来源
- Shaw J, Brenner M. Resuscitative Endovascular Balloon Occlusion of the Aorta: What You Need to Know. J Trauma Acute Care Surg. 2025. PMID: 39969564. doi:10.1097/TA.0000000000004534
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。